AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Vilglipt-M 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Vitabolik Pharma

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vilglipt-M 50/500 Tablet

Metformin/Vildagliptin 50/500 mg tablets combine two medications to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent severe diabetic complications like kidney disease and vision loss, potentially lowering heart attack and stroke risk. This medication may be prescribed independently or alongside other anti-diabetic treatments. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and other medications. Consuming this medication with food minimizes stomach upset. Consistent daily dosing at the same time maximizes benefits; discontinuation should only occur under medical guidance. Effective blood sugar control reduces the likelihood of future complications. Maintaining your prescribed diet and exercise routine is crucial for diabetes management; lifestyle choices significantly impact control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach discomfort, headache, pharyngitis, fatigue, GERD, diaphoresis, and decreased appetite. Hypoglycemia is a potential side effect, particularly when combined with insulin or sulfonylureas; understand its recognition and management. This medication isn't suitable for all individuals. Inform your physician of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption before starting treatment. Pregnant or breastfeeding individuals should seek medical consultation prior to use. Drug interactions are possible; disclose all medications to ensure safety. Alcohol should be limited due to its hypoglycemic effect. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Primary Ingredients of Vilglipt-M 50/500 Tablet

The provided text is "undefined," so there is nothing to rephrase.

Uses of Vilglipt-M 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Vilglipt-M 50/500 Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Vilglipt-M 50/500 Tablet with a meal.

Common Side effects of Vilglipt-M 50/500 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vilglipt-M 50/500 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Vilglipt-M 50/500 Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

How Vilglipt-M 50/500 Tablet works:

Metformin and vildagliptin, combined as Vilglipt-M 50/500, offer dual-action diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vilglipt-M 50/500 Tablet with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Vilglipt-M 50/500 tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Vilglipt-M 50/500 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Individuals with kidney impairment should exercise caution when using Vilglipt-M 50/500 tablets. Dosage modifications may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid Vilglipt-M 50/500 tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Vilglipt-M 50/500 Tablet :

Should you forget to take a Vilglipt-M 50/500 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Vilglipt-M 50/500 Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Treatment

FAQs on Vilglipt-M 50/500 Tablet

Vilglipt-M 50/500 Tablets rarely cause hypoglycemia by themselves, but it can happen if you don't eat enough while taking them. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. These symptoms are more likely if you skip meals, drink alcohol, overexert yourself, or take other diabetes medication. Regular blood sugar monitoring is crucial. Always keep glucose tablets, honey, or fruit juice on hand.
Nausea and vomiting are possible side effects of Vilglipt-M 50/500 Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take additional medications without your doctor's approval.
Vilglipt-M 50/500 Tablets are contraindicated in patients allergic to any component or excipient. This medication should also not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vilglipt-M 50/500 tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Vilglipt-M 50/500 Tablets can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue use and seek immediate medical attention.
Prolonged use of Vilglipt-M 50/500 Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia and neurological complications.
Using Vilglipt-M 50/500 Tablet as directed by your doctor is safe. However, even with correct usage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and hypoglycemia (low blood sugar, especially when combined with insulin or sulphonylurea) may occur. Report any persistent issues to your physician.
Vilglipt-M 50/500 Tablet
72
MRP 83
13% off